Adjuvant Chemotherapy in Patients With Clinical Stage III Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy
Status:
Recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of adjuvant chemotherapy in patients
with clinical stage III rectal cancer who received neoadjuvant chemoradiotherapy on the basis
of postoperative pathological stage.